The HHS Office on Women’s Health will host a virtual symposium to convene federal and non-federal stakeholders in the fields of research, prevention, and treatment focusing on the impact of endocrine disrupting chemicals on women’s health and to explore actionable solutions addressing evidence to policy and practice gaps.